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1.Introduction
  Antibodies (Abs) are produced by traditional method 
of animal immunization and modern methods based on 
hybridoma and recombinant DNA (rDNA) technologies 
for applications in diagnosis, treatment and bioscience 
research [1-3]. Several monoclonal antibodies (mAbs) have 
been developed by hybridoma technique and have been 
suitably modified for use as therapeutic agents in humans 
during the past three decades[4]. Although none yet licensed 
for use, Abs produced by modern rDNA technologies (rAbs) 
are cost-effective and promising to have wide ranging 
applications in areas such as therapeutics, diagnostics, 
micro-arrays and proteomics, biosensors, novel drug 
delivery systems, in vivo tumor targeting, disease-resistant 
plant varieties, abzymes, enzyme inhibitors, etc. [2,5]. 
Various formats of rAbs, such as single-chain Fv (scFv), 
single-domain Ab (dAb), diabody, triabody, minibody, bi-
specific Ab, etc. have been produced [6]. 
  Phage display technology employs a set of rDNA 
techniques to produce Ab libraries representing a huge 
number of Ag-specific clones displayed on phage particles, 
subsequent selection of a desired Ag-specific Ab clone 
and its further genetic modification for achieving intended 
effector function [7-8]. Numerous libraries of scFv fragments 
derived from Ig gene segments of humans and animal 
species have already been constructed [9]. Although other 
display systems based on yeast, bacteria, viruses and 
ribosomes have been developed [6], phage display remains 
most popular. 
  Unique features of 'heavy chain antibodies' (HCAbs) 
in camelids and sharks have allowed production of the 
smallest Ag-binders, composed of only one variable 
domain of Ab, by phage display technology [10]. HCAbs 
differ from their full-length counterparts in having two 
identical shorter heavy chains and lacking light chains 
in their structure, and occur naturally in members of the 
family Camelidae[11] and sharks. The so-called single-
domain Abs (dAbs) or 'nanobodies' are derived from 
variable domain of HCAb designated as VHH gene 
segments and have attracted great attention in recent years 
for applications in medicine and biology [12-13]. Nanobodies 
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are highly expressed in microbial cell culture, possess 
favorable biophysical properties including solubility and 
thermal stability, and are amenable to affinity maturation 
and other genetic modifications[14]. Nanobodies against 
several clinically and industrially useful Ags have already 
been produced [12-13]. Necessity of production of dAbs and 
other suitable Ab formats that neutralize bacterial toxins 
has also been felt for making available cost-effective and 
alternative therapeutic agents for toxinosis[6,15].      
  Staphylococcus aureus is the causative agent of clinically 
important human and animal diseases, such as, food 
poisoning, toxic shock syndrome, abscesses, osteomyelitis, 
endocarditis, mastitis, etc. [16-17]. Pathogenic staphylococci 
produce several exotoxins such as haemolysins(毩,毬,毭,毮), 
enterotoxins (SEA-SEE, SEG-SEI), toxic shock syndrome 
toxin-1 (TSST-1), leucocidin, etc. as important virulence 
determinants [18]. Some of the staphylococcal toxins are 
known to cause disease, and all such toxinoses can possibly 
be treated with antibodies. Anti-SEB and anti-TSST-1 
dAbs have already been produced from phage display 
library of the Arabian camel [15] and anti-毩-hemolysin 
dAb from shark phage display library [19]. The present study 
was undertaken with an objective to select and characterize 
Staphylococcus aureus 毬-hemolysin-neutralizing single-
domain antibodies from phage display library of Indian 
desert camel produced in our laboratory.
2. Materials and methods
2.1. Preparation of S. aureus Hlb-rich exoproteins
  Coagulase- and 毬-hemolysin (Hlb)-posi t ive 
Staphylococcus aureus isolated from a clinical bovine 
mastitis case was used for production of total exoproteins in 
the culture supernatant. The culture was grown in one litre 
of brain-heart infusion broth using standard bacteriological 
procedures and the supernatant was harvested by 
centrifugation at 5 000×g for 30 mins at 4 ℃. Grams staining 
of the culture was done to confirm the presence of Gram-
positive staphylococci. Hlb titre in the crude supernatant 
was determined[20].Then, Hlb-rich total exoproteins were 
prepared from the supernatant by precipitation with 65% 
saturated ammonium sulfate solution and dialysis against 
phosphate-buffered saline (PBS), pH 7.0[21]. The resultant 
partially purified Hlb-rich total exoprotein preparation was 
thus 100×concentrated from the original culture. 
2.2. Electro-elution of S. aureus exoproteins from 
polyacrylamide gel
  S. aureus exoproteins, further concentrated 25-fold by 
trichloroacetic acid (TCA) precipitation, dissolved in 
Laemmli's sample buffer and resolved by sodium dodecyl 
sulphate-polyacryamide gel electrophoresis (SDS-PAGE) 
under reducing conditions in 15% resolving gel[22]. The 
39 kDa, 27 kDa and 23 kDa size polypeptide bands were 
electro-eluted from the gel[23]. After dialysis against PBS, 
pH 7.0, the eluates were stored at -70 ℃. The molecular 
size (Mr) and purity of the eluates were verified by SDS-
PAGE in 12.5% resolving gel. 
2.3. Determination of protein concentration
  Protein concentrations in various preparations were 
determined against bovine serum albumin standard[24] using 
a commercial kit (Genei, Bangalore, India) in a microtitre 
plate version. 
2.4. SDS-PAGE
  SDS-PAGE of Hlb-rich exoproteins, electro-eluted 
exoproteins, expressed dAbs in periplasmic contents of 
E. coli host and purified dAbs was done under reducing 
conditions using Laemmli's discontinuous buffer system 
in 12.5% or 15% resolving gel and 4% stacking gel in a 
vertical gel electrophoresis apparatus[22].  
2.5. Western blotting
  Western blotting was performed essentially according to 
the method of Towbin and his colleagues (1979)[25]. Briefly, 
polypeptides resolved by SDS-PAGE were electro-blotted 
from the gel to methanol-pretreated polyvinyl difluoride 
(PVDF) membrane (0.22 滋m pore size) in a semi-dry trans-
blot apparatus (Atto® Corporation, Japan) at 1.0 mA/cm
2 of 
the gel for 1 hr at RT. Immunoblots were developed using 
following steps: i) washing in PBS-0.05% tween 20 (PBST) 
for 15 min, ii) blocking with the PBST-3%BSA for 1.5 hr, 
iii) 3伊5 min washings, iv) reaction with antibody [mouse 
anti-HA mAb (Cell Signal Technology® , USA) at 1:500 
dilution or with rabbit anti-dAb hyperimmune serum (HIS) 
at 1:3000 dilution for expressed dAb detection; purified 
dAb clones for exotoxins detection], 2 hrs at RT, v) 3伊5 min 
washings, vi) reaction with anti-species conjugate [anti-
mouse or anti-rabbit HRPO conjugate at 1:3 000 dilution] 
or rabbit anti-dAb followed by anti-rabbit conjugate for 
one hr at RT, vii) 4伊5 min washings as above and the 5 min 
last one in  citrate-phosphate buffer, pH 5.0 (CPB), viii) 
blot development with DAB/H2O2 substrate solution at RT 
in the dark until the background started just appearing, ix) 
stopping colour development with deionized water, x) drying 
the blots for photography.
2.6. Selection and enrichment of S. aureus exoproteins-
specific dAb-displaying phages from the phage display 
library
  S. aureus exoproteins-specific dAb-displaying phages 
from the display library were selected and enriched by 
the panning technique[15]. The phage display library of 
LPS-immunized Indian desert camel constructed in 
our laboratory was employed in the present study. The 
phage display library was a collection of >5伊107 M13/fd 
filamentous phages, each displaying a dAb on its minor coat 
protein, pIII, and encapsidating its corresponding VHH-
pHEN4 DNA. Three rounds of panning of the phage display 
library were performed to select and enrich S. aureus 
exoproteins-binding dAb-displaying M13 phages. 
  S. aureus exoprotein Ags (1.0 mg/ mL) in 50 mM PB, pH 
7.0 were coated 100 滋L/well at 4 ℃ O/N. After washing 3
伊3 min in PBS, pH 7.0, the Ag-coated wells were loaded 
with 100 滋L/well of >1011 virions/mL of the original phage 
library. The phages were allowed to bind at RT for 1 hr. and 
after extensive washing, eluted with triethylamine solution 
and neutralized with 1M Tris-HCl, pH 7.4. The Ag-specific 
phage eluates were designated as Pan-I/SAE. Pan-I/SAE 
phages were titrated by infecting TG1 cells. The Pan-I/
SAE phages were rescued with M13K07 helper phage and 
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amplified in TG1 cells to produce post-Pan-I phages for the 
second round of panning. In this manner, three rounds were 
completed.  
  Enrichment of Ag-specific phages in successive rounds of 
panning was determined by phage titration by TG1 infection 
[26] and phage-ELISA of post-Pan-I, -II, -III phage 
preparations [15]. Exponentially growing TG1 cells were 
infected with phages eluted at each round and plated onto 
LB/ampicillin/glucose agar plates for titre determination. 
The phages from infected TG1 cells in LB/ampicillin/
glucose broth were rescued with helper phage superinfection 
and prepared 1011 phages/mL for phage-ELISA, using 
S. aureus total exoproteins as coated Ag (1.0 mg/mL) and 
rabbit anti-M13K07 hyperimmune serum followed by anti-
rabbit IgG-HRPO conjugate for phage detection. 
2.7. Expression of selected Ag-specific soluble dAb.HA clones 
in WK6
  Amber non-suppressor WK6 cells were infected with 
the rescued post-Pan-III/SAE phages and 10 VHH-PCR 
tested clones of soluble dAb with C-terminal HA tag (dAb.
HA) were expressed from WK6 transformants obtained on 
LB/ampicillin agar plates. The periplasmic contents were 
released by hypotonic shock treatment[15], collected by high 
speed centrifugation, mixed with phenyl methyl sulphonyl 
fluoride (PMSF) to a final conc. 1 mM, and kept at -70 ℃ 
until further use. 
2.8. Subcloning of Ag-specific VHHs in pHEN6c vector, 
WK6 transformation and expression of dAb.6伊His in WK6 
transformants
  Standard protocols in molecular biology were used [27]. 
VHH clones, dAb/SAE Cl-3, Cl-6, Cl-7 and Cl-9, from 
selected Ag-specific VHH-pHEN4 clones, of 370-450 
bp size were amplified by PCR, gel extracted and ligated 
with pHEN6c DNA into PstI and BstEII (Eco91l) sites 
at 16 ℃ O/N using T4 DNA ligase. The ligated VHH-
pHEN6c transformed into chemi-competent WK6. The 
vector, pHEN6c is a derivative of pHEN4 that allows IPTG-
inducible expression of soluble dAb with C-terminal 6伊
His tag in WK6 periplasm. A total of 14 transformant WK6 
colonies were screened by VHH-PCR and the positive 
transformants used for expression of dAb.6伊His clones in 
periplasm. The periplasmic expression was assessed in 
12.5% resolving gels in SDS-PAGE and Ag-specificity 
of dAb.6伊His clones detected by indirect ELISA, using S. 
aureus total exoproteins Ag (10 µg/mL) coated onto 96-wells 
ELISA plate (Nunc Maxisorb® , Denmark). Soluble dAb.6
伊His clones in WK6 periplasmic contents were detected 
using rabbit anti-dAb HIS followed by anti-rabbit IgG 
-HRPO conjugate. 
2.9. Purification of soluble dAb.6伊His clones
  Three Ag-specific dAb.6伊His clones showing relatively 
higher A492 values in indirect ELISA were selected 
further for expression in WK6 periplasm and subjected to 
purification by Ni-TED affinity column chromatography 
according to manufacturer's protocol (USB®, USA) or Ni-
NTA affinity chromatography in batch-mode (Invitrogen, 
USA) followed by ultra-filtration through 30 kDa cut-off 
membrane (Amicon® , USA). 
2.10. Characterization of the purified dAb.6伊His clones
  Ag-specific purified dAb.6伊His clones were tested for 
Ag specificity by indirect ELISA and western blotting. For 
indirect ELISA, S. aureus total exoproteins (20 µg/mL) 
and three gel-extracted S. aureus exoproteins, viz., SAE-
p39, SAE-p27 and SAE-p23 (5 µg/mL each) were coated 
onto wells of an ELISA plate (Nunc Maxisorb® , Denmark), 
blocked with PBST-10% horse serum, reacted with purified 
dAb.6伊His clones, viz., Cl-7-1, Cl-7-5 and Cl-9-2 O/N 
at 4 ℃ , and detected with rabbit anti-dAb IgG followed by 
conjugate. Western blotting of the four Ags was done with 
all the three dAb.6伊His clones.   
2.11. Neutralization of S. aureus Hlb activity in vitro 
  Staphylococcus aureus was grown fresh and the supernatant 
containing exoproteins was harvested from the culture 
and Hlb activity in the culture supernatant titrated. For 
demonstration of Hlb neutralization with three dAb.6伊His 
clones (i.e., Cl-7-1, Cl-7-5 and Cl-9-2), serial 2-fold 
dilution starting from neat to 1:128 of each purified dAb.6
伊His clone was made using 'toxin diluent buffer' (PBS, pH 
7.4 with 10 mm MgCl2) buffer in a volume of 50 µL/well in a 
96-wells U-bottom microtitre plate. Then, Hlb-containing 
culture supernatant was diluted in the toxin diluent buffer 
so as to contain five hemolytic units of Hlb and added in 
a volume of 50 µL/well in all the wells of different dAb.6伊
His dilutions. BHI broth and toxin diluent were the negative 
control. The plate was then incubated at 37 ℃ for half an 
hour to allow Hlb-dAb.6伊His interactions. 
  One percent sheep RBC suspension was added 50 µL/well 
in all the wells, mixed with Hlb dilutions and incubated 
for one hr at 37 ℃. Sheep RBCs settled in the wells were 
resuspended and the plate transferred to refrigerator at 
4 ℃ for two hrs. Sheep RBC buttons at the bottom of wells 
were taken as indicator of Hlb neutralization by dAb6伊His 
clones. Hlb neutralization titre was calculated as reciprocal 
of the highest dilution of the purified dAb clone(s) that 
completely inhibited hemolysis by five Hlb units.
2.12. Examination of thermal inactivation
  For determination of thermal inactivation of purified dAb.6
伊His clones, each clone was incubated in a temperature 
gradient thermal cycler at 37 ℃, 50 ℃, 60.5 ℃, 70.9 ℃, 
80 ℃, 89.9 ℃ and 99 ℃ for 30 min followed by cooling to 
4 ℃ for 5 min. Then, 2-fold serial dilutions of each clone 
were made in toxin diluent buffer in a U-bottom microtitre 
plate and neutralization of two hemolytic units of Hlb 
recorded as indicator of resistance to thermal inactivation. 
2.13.DNA sequencing of S. aureus Hlb-neutralizing dAb 
clone
  DNA sequence of anti-S. aureus Hlb dAb Cl7-5 
was determined using automatic sequencing facility at 
Chromous Biotech Pvt. Ltd., Bangalore, India and the 
sequence submitted to NCBI GenBank [GenBank via 
Bankit:http://www.ncbi.nlm.nih.gov/Banklt/]. Immuno- and 
bioinformatics techniques were used to reveal the molecular 
biological features of the clone.
Pooja Jangra  et al./Asian Pacific Journal of Tropical Medicine (2010)1-74
3. Results
3.1. S. aureus exoproteins profiling by SDS-PAGE
  The polypeptide profile of the Hlb-rich total exoproteins 
obtained in 15% resolving gel by SDS-PAGE under 
reducing conditions is shown in Figure 1A. Several major 
bands were revealed and Mr size ranged between 10 kDa 
and 150 kDa. The most prominent band was of 38.8 kDa 
size approximately, called SAE-p39. Other major bands 
of 50.1 kDa (SAE-p50), 31.6 kDa (SAE-p32), 28.8 kDa 
(SAE-p29), 26.9 kDa (SAE-p27), 23.4 kDa (SAE-p23), 
19.4 kDa (SAE-p19), 14.4 kDa (SAE-p14), etc. were also 
visible in the CBBR-stained gel as shown in the figure.
  SAE-p39, SAE-p27 and SAE-p23 polypeptides, electro-
eluted from SDS-polyacrylamide gel, appeared as single 
bands of ~39 kDa, ~27 kDa, and ~23 kDa size in 15% 
resolving gel of SDS-PAGE (Figure 1B).
 A: Lane 1: Protein Mr markers, 2: S. aureus total exoproteins, B : 
Lane 1: Protein Mr markers, 2: S. aureus Hlb-rich total exoproteins, 3: 
SAE-p39, 4: SAE-p27, 5: SAE-p23
Figure 1 A-B. SDS-PAGE profile of ammonium sulfate precipitated 
S. aureus total exoproteins (A) and gel electro-eluted purified 
exoproteins (B). 
3.2. Selection and enrichment of Ag-specific dAb-displaying 
phages from the phage library
  Pan-I, -II and -III eluted phage titration and phage-
ELISA results are shown in Table 1. Difference of CFU 
counts obtained with phages after the first and the third 
round of panning showed an enrichment factor of 168. A492 
values in phage-ELISA using Ag-specific phages increased 
in successive rounds of panning. Put together, the results 
indicated successful selection of Ag-specific phages from 
the original library. 
3.3. Expression of soluble dAb.HA in WK6 periplasmic 
contents
  All the nine VHH-positive WK6 transformants were found 
to express dAb.HA of approximately 16.5 kDa size in their 
periplasm as analyzed by SDS-PAGE in 15% resolving gel 
(Figure 2). However, only four clones, designated as dAb.
HA/SAE Cl-3, Cl-6, Cl-7, and Cl-9 had relatively higher 
levels of expression of dAb.HA. Immunoblot of dAb.HA 
Cl-9 developed with murine anti-HA monoclonal antibody 
showed only one brown band of ~16.5 kDa size (Figure 
3A). Whereas, immunoblots of other three clones i.e., Cl-3, 
Cl-6, and Cl-7 developed with rabbit anti-dAb HIS showed 
~16.5 kDa band, along with some additional bands in each, 
indicating the presence of anti- E. coli proteins exoproteins 
antibodies in rabbit anti-dAb HIS (Figure 3B). These 
findings confirmed the expression of expected size of dAbs 
with HA tag in the clones tested.
Lane 1: Protein Mr markers, 2-10: dAb.HA expressed in periplasmic 
content of Cl-1 & Cl-3 to Cl-10, 11-12: WK6 periplasmic contents 
as negative controls.
Figure 2. SDS-PAGE of periplasmic contents of WK6 clones 
expressing dAb.HA in 15% resolving gel. 
Lane 1: Coomassie blue stained PVDF strip of Protein Mr markers, 2: 
immunoblots of dAb.HA Cl-9 with mouse anti-HA monoclonal Ab, 
3-7: immunoblots of dAb.HA with rabbit anti- dAb.HA His, 3:WK6 
control, 4: Cl-3, 5: Cl-6, 6: Cl-7.
Figure 3 A-B. Immunoblots of periplasmic content of WK6 
expressing dAb.HA developed with: (A) mouse anti-HA monoclonal 
Ab and, (B) rabbit anti- dAb.HA His. 
3.4. Expression of Ag-specific dAb.6伊His clones
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  All the 14 VHH-positive WK6 transformants expressed 
dAb.6伊His of  16.5 kDa size in their periplasm as revealed 
by SDS-PAGE using 12.5% resolving gel, wherein WK6 
control did not showed any corresponding band. However, 
the levels of expression of dAb.6伊His clones were lower 
than those of dAb.HA. Only 4 of the 14 clones tested gave 
relatively higher A492 values as compared to WK6 control in 
indirect ELISA.
3.5. Purification and characterization of dAb.6伊His clones
  The dAb.6伊His clones purity achieved by Ni-TED affinity 
chromatography under native conditions was assessed by 
SDS-PAGE in 12.5% resolving gel. Of the three serial 
eluates from nickel chelate chromatography column, the 
first two eluates, i.e., El-I and El-II had a band of 16.5 kDa 
dAb.6xHis in both the clones, i.e., Cl-7-5 and Cl-9-2 in 
CBBR-stained gel (Figure 4), indicating satisfactory level 
of purity achievement. Eluate III of both the clones did not 
show any band, indicating that all the bound dAb.6伊His was 
completely/largely eluted with first two mL lots of the elution 
buffer used under native conditions.  
Lane 1: Protein Mr marker, 2-3: dAb.6伊His Cl-7-5 eluates El-I and 
El-II from Ni-TED column.
Figure 4. SDS-PAGE in 12.5% polyacrylamide gel showing dAb.6伊
His clones purified by Ni-TED chromatography. 
  Cl-7-1 and Cl-7-5 purified with Ni-NTA batch-mode 
chromatography under native conditions followed by 
ultrafilteration through 30 kDa cut-off membrane showed 
two major bands, one of ~16.5 kDa dAb.6伊His and the other 
of about 29 kDa in CBBR-stained gel. The purity achieved 
was thus not 100%, but substantial for further work using 
suitable control for the contaminant band. 
  The indirect ELISA results confirmed the Ag-specificity 
of the three clones used. The clones reacted with total 
exoproteins as well as SAE-p39 preparation, and did not 
react to SAE-p27 and SAE-p23 Ags. The immunoblots of 
four different S. aureus Ags, viz. Hlb-rich total exoproteins, 
SAE-p39, SAE-p27, SAE-p23 developed with each of the 
three purified dAb.6xHis clones showed the specific band of 
SAE-p39, but not SAE-p27 and SAE-p23. 
  Of the three clones tested, only one clone, i.e., Cl-7-5 
upto its 1:4 dilution completely inhibited five Hlb hemolytic 
units in vitro as indicated by SRBC button formation in 
the microtitre plate (Figure 5). The neat Cl-7-1, however, 
showed partial inhibition of two Hlb units only, whereas 
complete hemolysis occurred in all the wells having five Hlb 
hemolytic units mixed with serially 2-fold diluted Cl-9-2, WK6, 
BHI, and the diluent control. The Cl-7-5 clone, heat-treated for 
30 mins. at 37℃, 50℃, 60.5 ℃, 70.9 ℃, 80℃, 89.9℃, and 
99℃ followed by cooling to 4℃ for 5 mins, inhibited two 
hemolytic units of β-hemolysin, thereby indicating its 
resistance to thermal inactivation.
Columns 1-5: serial 2-fold dilutions starting from neat; Col. 1: 
dAb.6xHis Cl-7-5; Col. 2: dAb.6伊His Cl-9-2; Col. 3: WK6 negative 
control; Col. 4: BHI negative control; Col. 5: toxin diluent as negative 
control.
Figure 5. Inhibition of 毬-hemolytic activity by purified dAb.6伊His 
clones in microtitre plate. 
3.6. DNA sequence and molecular biological features of S 
aureus Hlb-neutralizing camel dAb Cl7-5
  Comparison of deduced amino acid sequences of three 
clones from the same phage display library revealed that 
all had the key features of camelid VHH i.e., S11, F37, 
E44, R45 and G47 [anti-S. aureus dAb Cl7-5 (GenBank 
Accession no.: GU014816)]/E47 [randomly chosen Cl2 
(Genbank Accession no.: EU429319)]/K47 anti-LPS 
dAb Cl26 (GenBank Accession no.: EU861212)] (Kabat 
numbering of VHH domain). However, CDR1 and CDR3 
were of exceptionally large size, having 14 and 27 amino 
acids respectively in GU014816. All the three also gave a 
3-D structure based on 1jtpA (anti-lysozyme camel dAb) 
template using Swiss 3D modeling. 
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4. Discussion
  A local isolate of S. aureus from bovine mastitis 
case was used. The isolate was positive for coagulase, 
catalase and some exoproteins including β-hemolysin 
(unpublished observations). Hlb or β-toxin was verified 
by demonstration of the 'hot-cold' hemolytic activity in the 
culture supernatant with a titre of 128 and the presence of 
the most abundant protein of 39 kDa size (SAE-p39) in the 
65% ammonium sulphate precipitated preparation resolved 
by SDS-PAGE. According to Projan and colleagues (1989)
[28], the molecular size of the full-length Hlb was 39 kDa. 
Later on, it was suggested that the mature secreted product 
had a molecular size of 35 kDa[18]. The findings of the 
present study, however, agree with that of Projan and his 
colleagues (1989)[28]. Most of the S. aureus isolates from 
bovine mastitis secrete β-hemolysin along with a wide 
variety of other exoproteins[17]. 
  Hlb was chosen for several reasons: i) it is secreted 
by most bovine strains of S. aureus, and its role in 
pathogenesis of udder infections is implicated, though not 
clearly understood, ii) Hlb-neutralizing dAb or other rAb 
formats have yet not been reported in the literature, iii) it 
has sphingomyelinase C activity, having homology with 
sphingomyelinases from several bacterial species, such as 
Bacillus cereus, Listeria ivanovi, Leptospira interrogans, etc.
[29], to cause damage of cells of the hematopoietic origin, 
brain and other tissues of animal species having high 
sphingomyelin content. Neutralizing antibodies against 
this enzyme should therefore be useful in diminishing or 
preventing the damage caused by Hlb during S. aureus 
infection. 
  However, the levels of expression were not high, which 
pointed out the need for increasing the expression levels 
by trying different conditions of expression in a prokaryotic 
system[30] or eukaryotic system[31]. Neutralization of the 
β-hemolytic activity was the most revealing of the bio-
activity of the expressed clones. Out of the three clones 
tested, dAb/SAE Cl-7-5 completely neutralized five 
haemolytic units of Hlb in vitro. Whereas, dAb/SAE Cl-7-1 
only partially neutralized only two units of Hlb and dAb/
SAE Cl-9-2 did not at all neutralize Hlb. This observation 
suggested that the three clones were probably detecting 
three different epitopes on the same antigen i.e. Hlb. 
However, possibility also existed that dAb/SAE Cl-7-1 
and dAb/SAE Cl-7-5 that originated from Cl-7 ancestor 
were detecting one and the same antigen but with different 
affinities. Interestingly, a dAb clone was found to resist 
thermal denaturation even up to 99 ℃. Thermal resistance 
of dAbs has been explained by some investigators [32-
33]. Small size, additional Cys residues in the amino acid 
sequence and ability to rapidly renature are supposed to 
be responsible for this feature of dAbs, which the dAbs in 
the present study also share. In addition, subjecting the 
dAb clones to a range of elevated temperatures, followed 
immediately by cooling to 4 ℃ prior to their mixing with 
Hlb, might have rapidly renatured the clone. Another 
interesting point that emerges from these findings is that if 
the dAb is neutralizing Hlb as an enzyme, then it must have 
some special features in its paratope[34]. The antibody must 
be able to bind in the active site or nearby to cause stereic 
hindrance to the substrate binding.
  One dAb clone, i.e., anti-SAE-p39 showing neutralization 
of S. aureus β-toxin in vitro was the most significant finding 
in the present study. Another application that the dAb clone 
could find is its use in developing immunosensor-based 
diagnostic test for detection of Hlb-secreting S. aureus 
isolates. Only the dAbs have been reported to be suitable for 
immobilization on the biosensor chip, because of their small 
size, exceptional stability and good affinity. Immunosensor-
based diagnostics are proving better than ELISA technique 
due to their being highly sensitive (fM/mL), rapid giving 
result within 10 mins and linear over a wider range of 
concentrations [35].
  In conclusion, camel single-domain antibody that 
neutralizes  S. aureus 毬-hemolysin has been isolated and 
partially characterized, and suggested to have potential for 
applications in S. aureus disease diagnosis, therapeutics and 
research. 
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Table 1 
Successive enrichment of antigen-specific phages in three rounds of panning indicated by eluted phage titres, VHH-PCR and Phage-
ELISA. 
Panning  round Input dAb-displaying phages Output Ag-specific phages
VHH-PCR positive TG1 
transformants(% positive)*
Phage ELISA
(A492values)**
I
4.5伊1011 
(original library)
8.0伊106
(Pan-I/SAE)
15/16 (93.7%) 0.661
II
7.0伊1011 
(post- Pan-I phages)
6.0伊108
(Pan-II/SAE)
16/17 (94.1%) 0.763
III
8.7伊1011 
(post- Pan-II phages)
2.6伊109
(Pan-III/SAE)
16/17 (94.1%) 1.477
* About 80% of TG1 transformants in the original library were VHH-PCR positive; ** A492value of M13KO7 helper phage control & original 
phage library was 0.197 and 0.345, respectively.  
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